Phase Ib/II Trial of the Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Combination with Rituximab and Lenalidomide in Refractory/Recurrent Primary (PCNSL) and Secondary Central Nervous System Lymphoma (SCNSL)
| Autor: | Grommes, Christian, Piotrowski, Anna *, Pentsova, Elena *, Gavrilovic, Igor *, Stone, Jacqueline B *, Lin, Andrew *, Wongchai, Venissala *, Madzsar, Juli T *, Malani, Rachna *, Nolan, Craig *, Francis, Jasmine *, DeAngelis, Lisa *, Schaff, Lauren *, Mellinghoff, Ingo K * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3807-3808 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|